According to Tanaka et al., Tregs heavily infiltrate the TME of a variety of human tumors, such as gastrointestinal tumors, lung cancer, and breast cancer, where they mediate immunosuppression via CTLA4. Here, CTLA4 is linked to breast carcinoma.